Work

Impact of Anemia and SGLT-2 Inhibition on Renal Microvascular Oxygen Tension: Evidence for Renal Hypoxia Sensing

Year: 2021
Type: dissertation
Abstract: Sodium glucose linked transporter 2 (SGLT2) inhibitors have been demonstrated to improve cardiovascular outcomes in patients with type 2 diabetes mellitus; by mechanisms unknown. Probability analyses have estimated that an increase in erythropoiesis may contribute to these positive outcomes. We have utilized translational animal models to investigate the impact of anemia, hyperoxia, and SGLT2 inhibitors in control and diabetic rats, to assess the impact of these treatments on renal microvascular PO2. We have demonstrated that anemia and hyperoxia alter the renal microvascular PO2 proportionally to arterial blood oxygen content. By contrast, rats with diabetes treated with the SGLT2 inhibitor dapagliflozin showed decreased renal microvascular PO2 in the renal outer medullary region, increased renal erythropoietin RNA levels, and possible evidence of enhanced erythropoiesis. This suggests that mild renal tissue hypoxia is responsible for increasing hematocrit with SGLT2 inhibition, providing insight into the potential mechanism by which SGLT2 inhibition improves cardiovascular outcomes.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7057118416
Cites: 99
Cited by:
Related to: 10